Valeant buys Visudyne drug from QLT; QLT stock jumps

TORONTO (Reuters) - Valeant Pharmaceuticals International Inc said on Monday it has acquired Visudyne, a drug used to treat age-related blindness, from Canadian biotech firm QLT Inc for $112.5 million. QLT's shares jumped 7.4 percent after Mon...

Source: http://health.yahoo.net/news/s/nm/valeant-buys-visudyne-drug-from-qlt-qlt-stock-jumps

Facebook funny UBS AG Netflix